Canjuga, D.; Steinle, H.; Mayer, J.; Uhde, A.-K.; Klein, G.; Wendel, H.P.; Schlensak, C.; Avci-Adali, M.
Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium. Pharmaceutics 2022, 14, 1194.
https://doi.org/10.3390/pharmaceutics14061194
AMA Style
Canjuga D, Steinle H, Mayer J, Uhde A-K, Klein G, Wendel HP, Schlensak C, Avci-Adali M.
Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium. Pharmaceutics. 2022; 14(6):1194.
https://doi.org/10.3390/pharmaceutics14061194
Chicago/Turabian Style
Canjuga, Denis, Heidrun Steinle, Jana Mayer, Ann-Kristin Uhde, Gerd Klein, Hans Peter Wendel, Christian Schlensak, and Meltem Avci-Adali.
2022. "Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium" Pharmaceutics 14, no. 6: 1194.
https://doi.org/10.3390/pharmaceutics14061194
APA Style
Canjuga, D., Steinle, H., Mayer, J., Uhde, A. -K., Klein, G., Wendel, H. P., Schlensak, C., & Avci-Adali, M.
(2022). Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium. Pharmaceutics, 14(6), 1194.
https://doi.org/10.3390/pharmaceutics14061194